Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
JOYY ADR | YY | Nov 27, 2024 | 38.70 | +10.57 |
JP Morgan Chase | JPM | Nov 27, 2024 | 249.79 | -0.07 |
JP Morgan Chase & Co EE Pref | JPM-C | Nov 27, 2024 | 25.40 | +0.16 |
JP Morgan Chase & Co GG Pref | JPM-J | Nov 27, 2024 | 22.11 | -0.09 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Nov 27, 2024 | 25.09 | -0.04 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Nov 27, 2024 | 56.68 | -0.51 |
Jumia Technologies ADR | JMIA | Nov 27, 2024 | 3.98 | +0.51 |
Junee Limited - Ordinary Shares | JUNE | Nov 27, 2024 | 4.72 | +0.85 |
Junior Gold Miners ETF Market Vectors | GDXJ | Nov 27, 2024 | 47.17 | +1.07 |
Juniper Networks | JNPR | Nov 27, 2024 | 36.07 | +0.14 |
JVSPAC Acquisition | JVSAU | Nov 27, 2024 | 10.90 | 0.00 |
JVSPAC Acquisition | JVSA | Nov 27, 2024 | 10.39 | 0.00 |
JX Luxventure | JXJT | Nov 27, 2024 | 1.25 | -3.85 |
Kadant | KAI | Nov 27, 2024 | 403.46 | -4.60 |
Kairos Pharma | KAPA | Nov 27, 2024 | 1.65 | 0.00 |
Kairous Acquisition | KACL | Nov 27, 2024 | 12.46 | 0.00 |
Kaiser Aluminium | KALU | Nov 27, 2024 | 81.66 | -0.02 |
Kaival Brands Innovations Group | KAVL | Nov 27, 2024 | 0.73 | +0.25 |
Kaixin Holdings | KXIN | Nov 27, 2024 | 1.98 | +1.02 |
Kala Bio | KALA | Nov 27, 2024 | 6.65 | +2.49 |
Kaltura | KLTR | Nov 27, 2024 | 2.16 | -0.46 |
KalVista Pharmaceuticals | KALV | Nov 27, 2024 | 10.09 | +1.10 |
Kamada | KMDA | Nov 27, 2024 | 5.81 | 0.00 |
Kandi Technologies Group | KNDI | Nov 27, 2024 | 1.26 | -0.79 |
Kanzhun ADR | BZ | Nov 27, 2024 | 12.58 | +3.28 |
Karat Packaging | KRT | Nov 27, 2024 | 30.46 | -1.46 |
Karooooo | KARO | Nov 27, 2024 | 44.36 | +7.91 |
Kartoon Studios | TOON | Nov 27, 2024 | 0.63 | -4.14 |
Karyopharm Therapeutics | KPTI | Nov 27, 2024 | 0.85 | -2.66 |
Katapult | KPLT | Nov 27, 2024 | 6.69 | +0.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.